Evidence map›Paper›PMID 39675719›Full record

ArticleThe Journal of biological chemistry2025

Prohibitin 1 tethers lipid membranes and regulates OPA1-mediated membrane fusion.

Tadato Ban, Kimiya Kuroda, Mitsuhiro Nishigori, Keisuke Yamashita, Keisuke Ohta, Takumi Koshiba

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cryo-EM structure of the prohibitin complex in open conformation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tadato BanDepartment of Protein Biochemistry, Institute of Life Science, Kurume University, Fukuoka, Japan.
Kimiya KurodaDepartment of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan.
Mitsuhiro NishigoriDepartment of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan.
Keisuke YamashitaDepartment of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan.
Keisuke OhtaAdvanced Imaging Research Center, Kurume University School of Medicine, Fukuoka, Japan.
Takumi KoshibaDepartment of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan. Electronic address: koshiba@kyudai.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prohibitins (PHBs) are ubiquitously expressed proteins in the mitochondrial inner membrane (MIM) that provide membrane scaffolds for both mitochondrial proteins and phospholipids. Eukaryotic PHB complexes contain two highly homologous PHB subunits, PHB1 and PHB2, which are involved in various cellular processes, including metabolic control through the regulation of mitochondrial dynamics and integrity. Their mechanistic actions at the molecular level, however, particularly those of PHB1, remain poorly understood. To gain insight into the mechanistic actions of PHB1, we established an overexpression system for the full-length recombinant protein using silkworm larvae and characterized its biophysical properties in vitro. Using recombinant PHB1 proteoliposomes reconstituted into MIM-mimicking phospholipids, we found that PHB1 forms an oligomer via its carboxy-terminal coiled-coil region. A proline substitution into the PHB1 coiled-coil collapsed its well-ordered oligomeric state, and its destabilization correlated with mitochondrial morphologic defects. Negative-staining electron microscopy revealed that homotypic PHB1-PHB1 interactions via the coiled-coil also induced liposome tethering with remodeling of the lipid membrane structure. We clarified that PHB1 promotes membrane fusion mediated by optic atrophy 1 (OPA1), a key regulator of MIM fusion. Additionally, the presence of PHB1 reduces the dependency of lipids and OPA1 for completing the fusion process. Our in vitro study provides structural insight into how the mitochondrial scaffold plays a crucial role in regulating mitochondrial dynamics. Modulating the structure and/or function of PHB1 may offer new therapeutic potential, not only for mitochondrial dysfunction but also for other cell-related disorders.

Indexed as

GTP PhosphohydrolasesMembrane FusionMembrane LipidsMitochondrial MembranesRepressor ProteinsAnimalsBombyxHumansLiposomesMitochondriaProhibitinsGTP PhosphohydrolasesLiposomesMembrane LipidsOPA1 protein, humanPHB protein, humanProhibitinsRepressor Proteinscoiled-coilmembrane fusionmitochondriaprohibitin 1proteoliposomes

Identifiers

PMID39675719
PMCPMC11760825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.